Neuroadrenergic dysfunction in obesity: An overview of the effects of weight loss

Current Opinion in Lipidology

Volumn 21, Issue 1, 2010, Pages 21-30

  Straznicky, Nora E ^a   Lambert, Gavin W ^a   Lambert, Elisabeth A ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Insulin resistance; Metabolic syndrome; Obesity; Sympathetic nervous system; Weight loss

Indexed keywords

GLUCOSE; INSULIN; NORADRENALIN;

ADRENERGIC SYSTEM; AUTONOMIC DYSFUNCTION; ENERGY EXPENDITURE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MUSCLE CONTRACTION; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; REVIEW; WEIGHT REDUCTION;

ANIMALS; HUMANS; OBESITY; REST; SYMPATHETIC NERVOUS SYSTEM; WEIGHT LOSS;

EID: 77649139289     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283329c62     Document Type: Review

References (101)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002; 288:1723-1727.
2. Nguyen NT, Magno CP, Lane KT, et al. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999-2004. J Am Coll Surg 2008; 207:928-934.
3. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation 2006; 113:898-918.
4. Ford ES. Risks for all cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome. A summary of the evidence. Diabetes Care 2005; 28:1769-1778.
5. Mancia G, Bousquet P, Elghozi J, et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007; 25:909-920.
6. Straznicky N, Eikelis N, Lambert E, Esler M. Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep 2008; 10:440-447.
7. Schlaich Mp, Kaye DM, Lambert E, et al. Relationship between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation 2003; 108:560-565.
8. Cuspidi CA, Meani S, Valerio C, et al. Age and target organ damage in essential hypertension: role of the metabolic syndrome. Am J Med 2007; 20:296-303.
9. Straznicky NE, Lambert ES, Lambert GW, et al. Effects of dietary weight loss on sympathetic activity and cardiac riskfactors associated with the metabolic syndrome. J Clin Endocrinol Metab 2005; 90:5998-6005.
10. Orchard TJ, Temprosa M, Goldberg R, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005; 142:611-619.
11. Grassi G, Esler M. How to assess sympathetic activity in humans. J Hypertens 1999; 17:719-734.
12. Esler M, Jennings G, Leonard P, et al. Contribution of individual organs to noradrenaline release in humans. Acta Physiol Scand Suppl 1984; 527:11-16.
13. Jamerson KA, Julius S, Gudbrandsson T, et al. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993; 21:618-623.
14. Grassi G, Bolla G, Servalle G, et al. Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique. J Hypertens 2008; 26:2185-2190.
15. Eisenhofer G. Sympathetic nerve function. Assessment by radioisotope dilution analysis. Clin Auton Res 2005; 15:264-283.
16. Kingwell BA, Thompson JM, Kaye DM, et al. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994; 90:234-240.
17. Watson AMD, Hood SG, Ramchandra R, et al. Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex. Am J Physiol Heart Circ Res 2007; 293:H798-H804.
18. Baumert M, Lambert GW, Dawood T, et al. Short-term heart rate variability and cardiac norepinephrine spillover in patients with depression and panic disorder. Am J Physiol Heart Circ Physiol 2009; 297:H674-H679.
19. Arai Y, Saul JP, Albrecht P, et al. Modulation of cardiac autonomic activity during and immediately after exercise. Am J Physiol Heart Circ Physiol 1989; 256:H132-H141.
20. Saul JP, Rea RF, Eckberg DL, et al. Heart rate and muscle sympathetic nerve variability during reflex changes in autonomic activity. Am J Physiol 1990; 258:H13-H21.
21. Straznicky NE, Howes LG, Barrington VE, et al. Effects of dietary lipid modification on adrenoceptor-mediated cardiovascular responsiveness and baroreflex sensitivity in normotensive subjects. Blood Pressure 1997; 6:96-102.
22. Flaa A, Aksnes TA, Kjeldsen SE, et al. Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism 2008; 57:1422-1427.
23. Matsumoto T, Miyawaki C, Ue H, et al. Comparison of thermogenic sympathetic response to food intake between obese and nonobese young women. Obes Res 2001; 9:78-85.
24. Lee ZSK, Critchley AJH, Tomlinson B, et al. Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese. Metabolism 2001; 50:135-143.
25. Rumantir MS, Vaz M, Jennings GL, et al. Neural mechanisms in human obesity-related hypertension. J Hypertens 1999; 17:1125-1133.
26. Huggett RJ, Burns J, Mackintosh AF, Mary DASG. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 2004; 44:1-6.
27. Grassi G, Dell'Oro R, Quarti-Trevano F, Scopelliti F. Neuroadrenergic and reflex abnormalities in patients with the metabolic syndrome. Diabetologia 2005; 48:1359-1365.
28. Lambert E, Straznicky N, Schlaich M, et al. Differing patterns of sympathoex-citation in normal-weight and obesity-related hypertension. Hypertension 2007; 50:862-868.
29. Grassi G. Qualitative assessment of sympathetic neural drive in cardio-metabolic disease. A new challenge. Hypertension 2007; 50:835-836.
30. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation 2002; 106:2533-2536.
31. Grassi G, Dell'Oro R, Facchini A, et al. Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normoten-sives. J Hypertens 2004; 22:2363-2369.
32. Beske SD, Alvarez GE, Ballard TP, Davy KP. Reduced cardiovagal baroreflex gain in visceral obesity: implications for the metabolic syndrome. Am J Physiol Heart Circ Physiol 2002; 282:H630-H635.
33. Vaz M, Jennings G, Turner A, et al. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96:3423-3429.
34. Koskinen T, Kahonen M, Jula A, et al. Metabolic syndrome and short-term heart rate variability in young adults. The Cardiovascular Risk in Young Finns study. Diabet Med 2009; 26:354-361.
35. Stein PK, Barzilay JI, Domitrovich PP, et al. The relationship of heart rate and heart rate variability to nondiabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health study. Diabet Med 2007; 24:855-863.
36. Sung J, Choi YH, Park JB. Metabolic syndrome is associated with delayed heart rate recovery after exercise. J Korean Med Sci 2006; 21:621-626.
37. Kuo LE, Kitlinska JB, Tilan JU, et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 2007; 13:803-811.
38. Brunner EJ, Hemingway H, Walker BR, et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome. Circulation 2002; 106: 2659-2665.
39. Ljung T, Holm G, Friberg P, et al. The activity of the hypothalamic-pituitary- adrenal axis and the sympathetic nervous system in relation to waist/hip circumference ratio in men. Obes Res 2000; 8:487-495.
40. Grassi G, Servalle G, Dell'Oro R, et al. Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. Hypertension 2001; 38:1316-1320.
41. Baura GD, Foster DM, Kaiyala K, et al. Insulin transport from plasma into the central nervous system is inhibited by dexamethasone in dogs. Diabetes 1996; 45:86-90.
42. Bazelmans J, Nestel PJ, Esler MD. Blunted norepinephrine responsiveness to changing energy states in obese subjects. Metabolism 1985; 34:154-160.
43. Spraul M, Anderson EA, Bogardus C, Ravussin E. Muscle sympathetic nerve activity in response to glucose ingestion. Impact of plasma insulin and body fat. Diabetes 1994; 43:191-196.
44. Vollenweider P, Randin D, Tappy L, et al. Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 1994; 93:2365-2371.
45. Matsumoto T, Miyawaki T, Ue H, et al. Autonomic responsiveness to acute cold exposure in obese and nonobese young women. Int J Obes Relat Metab Disord 1999; 23:793-800.
46. Fagius J. Sympathetic nerve activity in metabolic control: some basic concepts. Acta Physiol Scand 2003; 177:337-343.
47. Muntzel MS, Anderson EA, Johnson AK, Mark AL. Mechanisms of insulin action on sympathetic nerve activity. Clin Exp Hypertens 1995; 17:39-50.
48. Straznicky NE, Lambert GW, Masuo K, et al. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin resistant metabolic syndrome. Am J Clin Nutr 2009; 89:27-36.
49. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999; 22:1462-1470.
50. Kern W, Benedict C, Schultes B, et al. Low cerebrospinal fluid insulin levels in obese humans. Diabetologia 2006; 49:2790-2792.
51. Schwartz MW, Figlewicz DF, Kahn SE, et al. Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats. Peptides 1990; 11:467-472.
52. Stein LJ, Dorsa DM, Baskin DG, et al. Reduced effect of experimental peripheral hyperinsulinemia to elevate cerebrospinal fluid insulin concentrations in obese Zucker rats. Endocrinology 1987; 121:1611-1615.
53. Kaiyala KJ, Prigeon RL, Kahn SE, et al. Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes 2000; 49:1525-1533.
54. Banks WA, Coon AB, Robinson SM, et al. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 2004; 53:1253-1260.
55. Urayama A, Banks WA. Starvation and triglycerides reverse the obesity-induced impairment of insulin transport at the blood-brain barrier. Endocrinology 2008; 149:3592-3597.
56. Carvalheira JBC, Ribeiro EB, Araujo EP, et al. Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats. Diabetologia 2003; 46:1629-1640.
57. Born J, Lange T, Kern W, et al. Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 2002; 5:514-516.
58. Hallschmid M, Benedict C, Schultes B, et al. Intranasal insulin reduces body fat in men but not in women. Diabetes 2004; 53:3024-3029.
59. Benedict C, Dodt C, Hallschmidt M, et al. Immediate but not long-term intranasal administration of insulin raises blood pressure in human beings. Metab Clin Exp 2005; 54:1356-1361.
60. Valentini M, Julius S, Palatini P, et al. Attenuation of haemodynamic, metabolic and energy expenditure responses to isoproterenol in patients with hypertension. J Hypertens 2004; 22:1999-2006.
61. Jocken JW, Blaak EE, Schiffelers S, et al. Association of beta-2-adrenoceptor (ADRB2) gene variant with a blunted in vivo lipolysis and fat oxidation. Int J Obesity 2007; 31:813-819.
62. Harris KF, Matthews KA. Interactions between autonomic nervous system activity and endothelial function: a model for the development of cardiovascular disease. Psychosom Med 2004; 66:153-164.
63. Strand AH, Gudmundsdottir H, Os I, et al. Arterial noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years. J Hypertens 2006; 24:905-913.
64. Burns J, Sivananthan MU, Ball SG. Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension. Circulation 2007; 115:1999-2005.
65. Mancia G, Bombelli M, Corrao G, et al. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazione (PAMELA) Study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 2007; 49:40-47.
66. Schlaich MP, Socratous F, Hennebry S, et al. Sympathetic activation in chronic kidney disease: causes, consequences and therapeutic implications. J Am Soc Nephrol 2009; 20:933-939.
67. Maser RE, Lenhard MJ. An overview of the effect of weight loss on cardiovascular autonomic function. Curr Diabet Rev 2007; 3:204-211.
68. Schlaich MP, Grassi G, Lambert GW, et al. European Society of Hypertension Working Group on Obesity. Obesity-induced hypertension and target organ damage: current knowledge and future directions. J Hypertens 2009; 27:207-211.
69. Masuo K, Kawaguchi H, Mikami H, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42:474-480.
70. Shigetoh Y, Adachi H, Yamagishi S, et al. Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population. Am J Hypertens 2009; 22:151-155.
71. Carnethon MR, Golden SH, Folsom AR, et al. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk in Communities study, 1987-1998. Circulation 2003; 107:2190-2195.
72. Porte D, Seeley RJ, Woods SC, et al. Obesity, diabetes and the central nervous system. Diabetologia 1998; 41:863-881.
73. Astrup A, Andersen T, Christensen NJ, et al. Impaired glucose-induced thermogenesis and arterial norepinephrine response persist after weight reduction in obese humans. Am J Clin Nutr 1990; 51:331-337.
74. Watanabe T, Nomura M, Nakayasu K, et al. Relationships between thermic effect of food, insulin resistance and autonomic nervous activity. J Med Invest 2006; 53:153-158.
75. Young JB, Landsberg L. Impaired suppression of sympathetic activity during fasting in the gold thioglucose-treated mouse. J Clin Invest 1980; 65:1086-1094.
76. Schwartz RS, Jaeger LF, Veith C, Lakshminarayan S. The effect of diet or exercise on plasma norepinephrine kinetics in moderately obese young men. Int J Obes 1990; 14:1-11.
77. Andersson B, Elam M, Wallin BG, et al. Effect of energy-restricted diet on sympathetic muscle nerve activity in obese women. Hypertension 1991; 18:783-789.
78. Grassi G, Servalle G, Colombo M, et al. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 1998; 97:2037-2042.
79. Karason K, Molgaard H, Wikstrand J, Sjostrom L. Heart rate variability in obesity and the effect of weight loss. Am J Cardiol 1999; 83:1242-1247.
80. Emdin M, Gastaldelli A, Muscelli E, et al. Hyperinsulinemia and autonomic nervous system dysfunction in obesity: effects of weight loss. Circulation 2001; 103:513-519.
81. Akehi Y, Yoshimatsu H, Kurokawa M, et al. VLCD-induced weight loss improves heart rate variability in moderately obese Japanese. Exp Biol Med (Maywood) 2001; 226:440-445.
82. Nakano Y, Oshima T, Sasaki S, et al. Calorie restriction reduced blood pressure in obesity hypertensives by improvement of autonomic nerve activity and insulin sensitivity. J Cardiovasc Pharmacol 2001; 38:S69-S74.
83. Trombetta IC, Batalha LT, Rondon MU, et al. Weight loss improves neuro-vascular and muscle metaboreflex control in obesity. Am J Physiol Heart Circ 2003; 285:H974-H982.
84. Laaksonen DE, Laitinen T, Schonberg J, et al. Weight loss and weight maintenance, ambulatory blood pressure and cardiac autonomic toneinobese persons with the metabolic syndrome. J Hypertens 2003; 21:371-378.
85. Machado MB, Velasco IT, Scalabrini-Neto A. Gastric bypass and cardiac autonomic activity: influence of gender and age. Obes Surg 2009; 19:332-338.
86. Straznicky N, Masuo K, Lambert G, et al. Sympathetic neural adaptation to hypocaloric diet and aerobic exercise in metabolic syndrome subjects [abstract]. J Hypertens 2008; 26 (Suppl 1):S352.
87. Alvarez GE, Davy BM, Ballard TP, et al. Weight loss increases cardiovagal baroreflex function in obese young and older men. Am J Physiol Endocrinol Metab 2005; 289:E665-E669.
88. Kansanen M, Vanninen E, Tuunainen A, et al. The effect of a very low calorie diet-induced weight loss on the severity of obstructive sleep apnoea and autonomic nervous function in obese patients with obstructive sleep apnoea syndrome. Clin Physiol 1998; 18:377-385.
89. Grassi G, Dell'Oro R, Seravalle G, et al. Short- and long-term neuroadre-nergic effects of moderate dietary sodium restriction in essential hypertension. Circulation 2002; 106:1957-1961.
90. Meredith IT, Friberg P, Jennings GL, et al. Exercise training lowers resting renal but not cardiac sympathetic activity in humans. Hypertension 1991; 18:575-582.
91. Fagerberg B, Andersson OK, Persson B, Hedner T. Reactivity to norepinephrine and effect of sodium on blood pressure during weight loss. Hypertension 1985; 7:586-592.
92. Webber J, Donaldson M, Allison SP, et al. The effects of weight loss in obese subjects on the thermogenic, metabolic and haemodynamic response to the glucose clamp. Int J Obes Relat Metab Disord 1994; 18:725-730.
93. BlaakEE, van BaakMA, Kester ADM, Saris VHM. p-Adrenergically mediated thermogenic and heart rate responses: effect of obesity and weight loss. Metabolism 1995; 44:520-524.
94. ReynisdottirS, Langin D, Carlstrom K, et al. Effects of weight reduction on the regulation of lipolysis in adipocytes of women with upper-body obesity. Clin Sci 1995; 89:421-429.
95. Barbe P, Stich V, Galitzky J, et al. In vivo increase in p-adrenergic lipolytic response in subcutaneous adipose tissue of obese subjects submitted to a hypocaloric diet. J Clin Endocrinol Metab 1997; 82:63-69.
96. Wahrenberg H, Ek I, Reynisdottir S, et al. Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1999; 84:2182-2187.
97. Lofgren P, Hoffstedt J, Naslund E, et al. Prospective and controlled studies of the actions of insulin and catecholamine in fat cells of obese women following weight reduction. Diabetologia 2005; 48:2334-2342.
98. Straznicky NE, Lambert GW, McGrane MT, et al. Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese subjects with metabolic syndrome. Diabetes 2009; 58:1126-1132.
99. Thorne A, Hallberg D, Wahren J. Meal-induced thermogenesis in obese patients before and after weight reduction. Clin Physiol 1989; 9:481-498.
100. Maffeis C, Schutz Y, Pinelli L. Postprandial thermogenesis in obese children before and after weight reduction. Eur J Clin Nutr 1992; 46:577-583.
101. Nelson KM, Weinsier RL, James LD, et al. Effect of weight reduction on resting energy expenditure, substrate utilization, and thermic effect of food in moderately obese women. Am J Clin Nutr 1992; 55:924-933.